News
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results